CytoMed Therapeutics ratios data for the quarter ended Dec 2025. These financial ratios cover 8 quarters of results from Dec 2021 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2021 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|
| Efficiency | ||||||||
| Assets AverageAssets Avg. | 8.84M | 11.54M | 10.04M | 9.24M | 7.96M | 7.26M | ||
| Invested CapitalInvested Cap. | 2.88M | 1.24M | 13.24M | 8.68M | 10.23M | 7.15M | 7.26M | 5.64M |
| Leverage & Solvency | ||||||||
| Debt Ratio | 0.22 | 0.22 | 0.01 | 0.04 | 0.01 | 0.05 | 0.00 | 0.06 |
| Valuation | ||||||||
| Price to BookP/B | 1.83 | 6.79 | 2.36 | 5.77 | 3.60 | 3.00 | ||
| Enterprise Value | 13.70M | 44.68M | 15.01M | 35.58M | 23.19M | 14.54M | ||
| Market Capitalization | 24.14M | 56.55M | 24.00M | 39.24M | 25.96M | 15.85M |